|
WO2015005985A1
|
|
Topical treatment of localized scleroderma
|
|
CN105050584A
|
|
Topical formulations of corticosteroids with enhanced bioavailability
|
|
US2014243300A1
|
|
Controlling the Bioavailability of Active Ingredients in Topical Formulations
|
|
WO2014093645A2
|
|
Topical formulations for increasing the dermal concentration of hyaluronic acid
|
|
EP2872167A1
|
|
Topical formulations comprising dna repair enzymes, and methods of use thereof
|
|
CN104363893A
|
|
Cyclodextrin-based microemulsions, and dermatological uses thereof
|
|
US2014243423A1
|
|
Stable, non-irritating topical formulations of hydroquinone
|
|
WO2013067271A2
|
|
Stable dermatological aerosol foams utilizing reactive propellants
|
|
CA2794503A1
|
|
Aerosol foams comprising clindamycin phosphate
|
|
CA2802041A1
|
|
High oil-content emollient aerosol foam compositions
|
|
EP2100601A2
|
|
Topical pharmaceutical foam composition
|
